Bernard M. Tijink

Bernard M. Tijink

Auto-generated profile, based on publicly available information

Bernard M. Tijink

Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2019 in Head & Neck
Verified
Journal Article
Open access
PDF file
SBSandra I. Bril
Sandra I. Bril
TPThomas F. Pezier
Thomas F. Pezier
BTBernard M. Tijink
Bernard M. Tijink
LJLuuk M. Janssen
Luuk M. Janssen
WBWeibel W. Braunius
Weibel W. Braunius
Remco De BreeRemco De Bree
Remco De Bree
Background: Low skeletal muscle mass (SMM) is associated with postoperative complications, prolonged hospital stay, and short overall survival (OS) in surgical oncology. We aimed to investigate this association in patients undergoing total laryngectomy (TL).Methods: A retrospective study was performed of patients undergoing TL. SMM was measured using CT or MRI scans at the level of the third cervical vertebra (C3).Results: In all, 235 patients were included. Low SMM was observed in 109 patients (46.4%). Patients with low SMM had more pharyngocutaneous fistulas (PCFs) than patients with normal SMM (34.9% vs 20.6%; P = .02) and prolonged hospital stay (median, 17 vs 14 days; P < .001). In multivariate analysis, low SMM (hazards ratio, 1.849; 95% confidence interval, 1.202‐2.843) and high N stage were significant prognosticators of decreased OS.Conclusion: Low SMM is associated with PCF and prolonged hospital stay in patients undergoing TL. Low SMM is an independent prognostic factor for shorter OS.

18 December 2022 in Brachytherapy
Verified
Journal Article
Open access
WSWillem Frederik Julius Scheurleer
Willem Frederik Julius Scheurleer
HDHoman Dehnad
Homan Dehnad
WBW. Weibel Braunius
W. Weibel Braunius
LJLuuk M. Janssen
Luuk M. Janssen
BTBernard M. Tijink
Bernard M. Tijink
JRJohannes A. Rijken
Johannes A. Rijken
Cancer of the nasal vestibule is a rare type of malignancy constituting less than one percent of all head and neck cancers. These tumors are typically diagnosed at an early stage. Both surgery and radiotherapy provide excellent oncological results, but esthetic results are better after radiotherapy. The aim of this study was to evaluate the long-term oncological follow-up after brachytherapy for early stage squamous cell carcinoma of the nasal vestibule. Retrospective analysis of patients with carcinoma of the nasal vestibule who were treated with primary brachytherapy in the Utrecht University Medical Center. In this single center experience over a 17-year period 68 patients with early stage squamous cell carcinoma of the nasal vestibule were treated with brachytherapy. Two patients had lymph node metastases at first clinical presentation. Median follow-up duration was 46.5 months. Five-year locoregional recurrence-free survival, disease-specific survival, and overall survival were 91.1%, 96.1%, and 66.2%, respectively. All recurrences occurred within the first 3 years of follow-up. Brachytherapy offers excellent oncological outcomes and is a safe and effective treatment for early stage carcinoma of the nasal vestibule. Recurrences typically occur within 3 years after treatment.

6 May 2021 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
RMRutger Mahieu
Rutger Mahieu
ITInne J. Den Toom
Inne J. Den Toom
RRRob van Rooij
Rob van Rooij
RERobert J. J. van Es
Robert J. J. van Es
MHMonique G. G. Hobbelink
Monique G. G. Hobbelink
Remco De BreeRemco De Bree
Remco De Bree

26 July 2023 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Open access
PDF file
RMRutger Mahieu
Rutger Mahieu
BTBernard M. Tijink
Bernard M. Tijink
RERobert J. J. van Es
Robert J. J. van Es
BNBastiaan J. van Nierop
Bastiaan J. van Nierop
CBCasper Beijst
Casper Beijst
Remco De BreeRemco De Bree
Remco De Bree
Purpose: Evaluating the Crystal Cam handheld gamma-camera for preoperative and intraoperative sentinel lymph node (SLN) localization in early-stage oral cancer. Methods: The handheld gamma-camera was used complementary to conventional gamma-probe guidance for intraoperative SLN localization in 53 early-stage oral cancer patients undergoing SLN biopsy. In 36 of these patients, a blinded comparison was made between preoperative handheld gamma-camera and lymphoscintigraphy outcomes. Of those, the reliability for marking the SLN’s location using both handheld gamma-camera and a 57Co-penpoint marker was evaluated in 15 patients. Results: In the entire cohort, the handheld gamma-camera preoperatively detected 116/122 (95%) of SLNs identified by lymphoscintigraphy. In those patients where the observer was blinded for lymphoscintigraphy (n = 36), 71/77 (92%) SLNs were correctly identified by handheld gamma-camera. Overlooked SLNs by handheld gamma-camera were mainly located near the injection site. The SLN’s marked location by handheld gamma-camera and 57Co-penpoint marker was considered accurate in 42/43 (98%) SLNs. The intraoperative use of the handheld gamma-camera led to the extirpation of 16 additional ‘hot’ lymph nodes in 14 patients, 4 of which harbored metastases, and prevented 2 patients (4%) from being erroneously staged negative for nodal metastasis. In those with follow-up ≥ 24 months or false-negative outcomes < 24 months following SLNB, a sensitivity of 82% and negative predictive value of 93% was obtained. Conclusion: The Crystal Cam handheld gamma-camera offers reliable preoperative and intraoperative SLN localization and might reduce the risk of missing a malignant SLN during surgery. Detecting SLNs near the injection site by handheld gamma-camera remains challenging.

11 November 2023 in Case Reports in Otolaryngology
Verified
Journal Article
Open access
PDF file
WSWillem Frederik Julius Scheurleer
Willem Frederik Julius Scheurleer
WBWeibel Braunius
Weibel Braunius
BTBernard M. Tijink
Bernard M. Tijink
LJLuuk M. Janssen
Luuk M. Janssen
FPFrank A. Pameijer
Frank A. Pameijer
JRJohannes Rijken
Johannes Rijken
Background. Sinonasal teratocarcinosarcoma is a rare, aggressive malignancy located almost exclusively in the nasal cavity, paranasal sinuses, or anterior skull base. Histopathological diagnosis can be challenging due to the heterogeneous composition. Methods. Retrospective analysis of 3 patients with sinonasal teratocarcinosarcoma diagnosed and treated at the University Medical Center Utrecht was conducted. Results. Patients presented with nasal obstruction, epistaxis, headaches, or behavioral changes. All three patients had locally advanced disease, and one had lymph node metastases. Two patients underwent surgery followed by radiotherapy, and one underwent neoadjuvant chemotherapy followed by surgery. The follow-up duration ranged from 3 to 32months. All three patients died due to progression of their disease. Conclusion. Sinonasal teratocarcinosarcoma is characterized by rapid, aggressive local expansion. The prognosis is poor due to a high risk of metastases and locally recurrent disease. Multimodality treatment consisting of surgery, followed by (chemo)radiotherapy, is essential for optimizing outcomes. Neoadjuvant therapy offers a promising treatment option.